Search tool

Displaying 1 - 6 of 6

25 years of monitoring and responding to new drugs in Europe — update published today

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary. Operated by the EMCDDA, in close cooperation with Europol and partners (1), it was the...

European Drug Report 2022: Trends and Developments

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set...

Close of up of synthetic cannabinoids

Spotlight on… Synthetic cannabinoids

Synthetic cannabinoids (or synthetic cannabinoid receptor agonists) is the name given to a diverse range of substances that act on the same brain receptors as tetrahydrocannabinol (THC), the main psychoactive ingredient in...

close-up of synthetic cannabinoid

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA). Widely available across Europe and highly potent, these substances are placing some users at...

Synthetic cannabinoids in Europe – a review

This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the the EU Early Warning System. The aim of this report is to...

close-up of synthetic cannabinoid

Spotlight on… Synthetic cannabinoids

What are synthetic cannabinoids? Synthetic cannabinoids (or synthetic cannabinoid receptor agonists) is the name given to a diverse range of substances that act on the same brain receptors as tetrahydrocannabinol (THC), the...